Ischaemic postconditioning: Cardiac protection after the event

Anaesthesia

Volumn 70, Issue 5, 2015, Pages 598-612

  Jivraj, N ^a   Liew, F ^a   Marber, M ^b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c BHF Centre for Regenerative Medicine and BHF Centre of Excellence and the Biomedical Research Centre at Guy s St Thomas NHS Foundation Trust and King s College London   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYCLOSPORIN; ERYTHROPOIETIN;

ALGORITHM; CLINICAL PRACTICE; COMPARATIVE STUDY; EXPERIMENTAL MODEL; HAPLORHINI; HEALTH CARE PLANNING; HEART DISEASE; HEART EJECTION FRACTION; HEART PROTECTION; HEART SURGERY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; ISCHEMIC POSTCONDITIONING; META ANALYSIS (TOPIC); NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; RABBIT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW (TOPIC); HEART DISEASES; HEART MUSCLE REPERFUSION; MORTALITY; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PROCEDURES;

CARDIAC SURGICAL PROCEDURES; HEART DISEASES; HUMANS; ISCHEMIC POSTCONDITIONING; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION;

EID: 84927069764     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12974     Document Type: Review

References (114)

1. World Health Organization
2. Bloom D, Cafiero E, Jané-Llopis E, et al. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum, 2011.
3. Johnston SS, Curkendall S, Makenbaeva D, et al. The direct and indirect cost burden of acute coronary syndrome. Journal of Occupational and Environmental Medicine/American College of Occupational and Environmental Medicine 2011; 53: 2.
4. Hausenloy DJ, Erik Botker H, Condorelli G, et al. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovascular Research 2013; 98: 7-27.
5. Braunwald E, Kloner RA,. Myocardial reperfusion: a double-edged sword? Journal of Clinical Investigation 1985; 76: 1713-9.
6. Yellon DM, Hausenloy DJ,. Myocardial reperfusion injury. New England Journal of Medicine 2007; 357: 1121-35.
7. Heusch G,. Postconditioning: old wine in a new bottle? Journal of the American College of Cardiology 2004; 44: 1111-2.
8. Heusch G,. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013; 381: 166-75.
9. Kunst G, Klein AA,. Peri-operative anaesthetic myocardial preconditioning and protection-cellular mechanisms and clinical relevance in cardiac anaesthesia. Anaesthesia 2015; 70: 467-82.
10. Sivaraman V, Pickard MJ, Hausenloy DJ,. Remote ischaemic conditioning: cardiac protection from afar. Anaesthesia 2014; 70: doi: 10.1111/anae.12973.
11. Hausenloy DJ, Yellon DM,. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 2009; 204: 334-41.
12. Vinten-Johansen J, Granfeldt A, Mykytenko J, Undyala VV, Dong Y, Przyklenk K,. The multidimensional physiological responses to postconditioning. Antioxidants and Redox Signaling 2011; 14: 791-810.
13. Zhao ZQ,. Postconditioning in reperfusion injury: a status report. Cardiovascular Drugs and Therapy 2010; 24: 265-79.
14. Hansen PR, Thibault H, Abdulla J,. Postconditioning during primary percutaneous coronary intervention: a review and meta-analysis. International Journal of Cardiology 2010; 144: 22-5.
15. Schevchuck A, Laskey WK,. Ischemic conditioning as an adjunct to percutaneous coronary intervention. Circulation Cardiovascular Interventions 2013; 6: 484-92.
16. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. American Journal of Physiology Heart and Circulatory Physiology 2003; 285: H579-88.
17. Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, Heusch G,. Ischemic postconditioning: experimental models and protocol algorithms. Basic Research in Cardiology 2009; 104: 469-83.
18. Cour M, Gomez L, Mewton N, Ovize M, Argaud L,. Postconditioning: from the bench to bedside. Journal of Cardiovascular Pharmacology and Therapeutics 2011; 16: 117-30.
19. Hausenloy DJ,. Signalling pathways in ischaemic postconditioning. Journal of Thrombosis and Haemostasis 2009; 101: 626-34.
20. Manintveld OC, Te Lintel Hekkert M, van den Bos EJ, et al. Cardiac effects of postconditioning depend critically on the duration of index ischemia. American Journal of Physiology Heart and Circulatory Physiology 2007; 292: H1551-60.
21. Kin H, Zhao ZQ, Sun HY, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovascular Research 2004; 62: 74-85.
22. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV,. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. Journal of the American College of Cardiology 2004; 44: 1103-10.
23. Gomez L, Thibault H, Gharib A, et al. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. American Journal of Physiology Heart and Circulatory Physiology 2007; 293: H1654-61.
24. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M,. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005; 111: 194-7.
25. Fujita M, Asanuma H, Hirata A, et al. Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. American Journal of Physiology Heart and Circulatory Physiology 2007; 292: H2004-8.
26. Roubille F, Franck-Miclo A, Covinhes A, et al. Delayed postconditioning in the mouse heart in vivo. Circulation 2011; 124: 1330-6.
27. Iliodromitis EK, Georgiadis M, Cohen MV, Downey JM, Bofilis E, Kremastinos DT,. Protection from post-conditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Research in Cardiology 2006; 101: 502-7.
28. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC,. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005; 102: 102-9.
29. Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, Kerendi F,. Postconditioning-a new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Research in Cardiology 2005; 100: 295-310.
30. Halkos ME, Kerendi F, Corvera JS, et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Annals of Thoracic Surgery 2004; 78: 961-9; discussion 9.
31. Yin Z, Gao H, Wang H, et al. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways. Clinical and Experimental Pharmacology and Physiology 2009; 36: 756-63.
32. Przyklenk K, Maynard M, Darling CE, Whittaker P,. Aging mouse hearts are refractory to infarct size reduction with post-conditioning. Journal of the American College of Cardiology 2008; 51: 1393-8.
33. Boengler K, Buechert A, Heinen Y, et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circulation Research 2008; 102: 131-5.
34. Iliodromitis EK, Zoga A, Vrettou A, et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 2006; 188: 356-62.
35. Donato M, D'Annunzio V, Berg G, et al. Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits. Journal of Cardiovascular Pharmacology 2007; 49: 287-92.
36. Bouhidel O, Pons S, Souktani R, Zini R, Berdeaux A, Ghaleh B,. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. American Journal of Physiology Heart and Circulatory Physiology 2008; 295: H1580-6.
37. Przyklenk K, Maynard M, Greiner DL, Whittaker P,. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxidants and Redox Signaling 2011; 14: 781-90.
38. Raphael J, Gozal Y, Navot N, Zuo Z,. Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. Journal of Cardiovascular Pharmacology 2010; 55: 348-57.
39. Manning AS, Hearse DJ,. Reperfusion-induced arrhythmias: mechanisms and prevention. Journal of Molecular and Cellular Cardiology 1984; 16: 497-518.
40. Grech ED, Ramsdale DR,. Termination of reperfusion arrhythmia by coronary artery occlusion. British Heart Journal 1994; 72: 94-5.
41. Na HS, Kim YI, Yoon YW, Han HC, Nahm SH, Hong SK,. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. American Heart Journal 1996; 132: 78-83.
42. Galagudza M, Kurapeev D, Minasian S, Valen G, Vaage J,. Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. European Journal Cardio-Thoracic Surgery 2004; 25: 1006-10.
43. Ito W, Schafer HJ, Bhakdi S, et al. Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits. Cardiovascular Research 1996; 32: 294-305.
44. Kloner RA, Ganote CE, Jennings RB,. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. Journal of Clinical Investigation 1974; 54: 1496-508.
45. Mykytenko J, Kerendi F, Reeves JG, et al. Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Basic Research in Cardiology 2007; 102: 90-100.
46. Hale SL, Mehra A, Leeka J, Kloner RA,. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion. American Journal of Physiology Heart and Circulatory Physiology 2008; 294: H421-5.
47. Zhao JL, Yang YJ, You SJ, Cui CJ, Gao RL,. Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swines. Microvascular Research 2007; 73: 137-42.
48. Zhao ZQ, Velez DA, Wang NP, et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 2001; 6: 279-90.
49. Kin H, Wang NP, Mykytenko J, et al. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release. Shock 2008; 29: 761-8.
50. Penna C, Cappello S, Mancardi D, et al. Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Research in Cardiology 2006; 101: 168-79.
51. + overload. American Journal of Physiology Heart and Circulatory Physiology 2005; 288: H1900-8.
52. Wei Y, Ruan L, Zhou G, et al. Local ischemic postconditioning during primary percutaneous coronary intervention: a meta-analysis. Cardiology 2012; 123: 225-33.
53. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation 2005; 112: 2143-8.
54. Ma X, Zhang X, Li C, Luo M,. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. Journal of Interventional Cardiology 2006; 19: 367-75.
55. Yang XC, Liu Y, Wang LF, et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. Journal of Invasive Cardiology 2007; 19: 424-30.
56. Laskey WK, Yoon S, Calzada N, Ricciardi MJ,. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Catheterization and Cardiovascular Interventions 2008; 72: 212-20.
57. Thibault H, Piot C, Staat P, et al. Long-term benefit of postconditioning. Circulation 2008; 117: 1037-44.
58. Lin XM, Zhang ZY, Wang LF, et al. Attenuation of tumor necrosis factor-alpha elevation and improved heart function by postconditioning for 60 seconds in patients with acute myocardial infarction. Chinese Medical Journal 2010; 123: 1833-9.
59. Lonborg J, Holmvang L, Kelbaek H, et al. ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance. American Heart Journal 2010; 160: 1085-91.
60. Sorensson P, Saleh N, Bouvier F, et al. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 2010; 96: 1710-5.
61. Xue F, Yang X, Zhang B, et al. Postconditioning the human heart in percutaneous coronary intervention. Clinical Cardiology 2010; 33: 439-44.
62. Liu TK, Mishra AK, Ding FX,. [Protective effect of ischemia postconditioning on reperfusion injury in patients with ST-segment elevation acute myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39: 35-9.
63. Garcia S, Henry TD, Wang YL, et al. Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction. Journal of Cardiovascular Translational Research 2011; 4: 92-8.
64. Zhao CM, Yang XJ, Yang JH, et al. Effect of ischaemic postconditioning on recovery of left ventricular contractile function after acute myocardial infarction. Journal of International Medical Research 2012; 40: 1082-8.
65. Tarantini G, Favaretto E, Marra MP, et al. Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. International Journal of Cardiology 2012; 162: 33-8.
66. Thuny F, Lairez O, Roubille F, et al. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology 2012; 59: 2175-81.
67. Freixa X, Bellera N, Ortiz-Perez JT, et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. European Heart Journal 2012; 33: 103-12.
68. Sorensson P, Ryden L, Saleh N, Tornvall P, Arheden H, Pernow J,. Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction. BMC Cardiovascular Disorders 2013; 13: 22.
69. Hahn JY, Song YB, Kim EK, et al. Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation 2013; 128: 1889-96.
70. Dwyer NB, Mikami Y, Hilland D, et al. No cardioprotective benefit of ischemic postconditioning in patients with ST-segment elevation myocardial infarction. Journal of Interventional Cardiology 2013; 26: 482-90.
71. Mewton N, Thibault H, Roubille F, et al. Postconditioning attenuates no-reflow in STEMI patients. Basic Research in Cardiology 2013; 108: 383.
72. Roubille F, Mewton N, Lairez O, et al. Delayed postconditioning in STEMI patients. European Heart Journal 2013; 34: 76-7.
73. Limalanathan S, Andersen GØ, Klow N-E, Abdelnoor M, Hoffmann P, Eritsland J,. Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI. Results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial. Journal of the American Heart Association 2014; 3: e000679.
74. Lonborg J, Kelbaek H, Vejlstrup N, et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circulation Cardiovascular Interventions 2010; 3: 34-41.
75. Kloner RA,. Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circulation Research 2013; 113: 451-63.
76. Ovize M, Mewton N,. Interventional cardiology: ischaemic POSTconditioning-a long harvest for a little corn. Nature Reviews Cardiology 2013; 11: 8-10.
77. Hausenloy DJ, Boston-Griffiths E, Yellon DM,. Cardioprotection during cardiac surgery. Cardiovascular Research 2012; 94: 253-65.
78. Luo W, Li B, Lin G, Huang R,. Postconditioning in cardiac surgery for tetralogy of Fallot. Journal of Thoracic and Cardiovascular Surgery 2007; 133: 1373-4.
79. Li B, Chen R, Huang R, Luo W,. Clinical benefit of cardiac ischemic postconditioning in corrections of tetralogy of Fallot. Interactive Cardiovascular and Thoracic Surgery 2009; 8: 17-21.
80. Luo W, Li B, Chen R, Huang R, Lin G,. Effect of ischemic postconditioning in adult valve replacement. European Journal Cardio-Thoracic Surgery 2008; 33: 203-8.
81. Piot C, Croisille P, Staat P, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. New England Journal of Medicine 2008; 359: 473-81.
82. Mahaffey KW, Puma JA, Barbagelata NA, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. Journal of the American College of Cardiology 1999; 34: 1711-20.
83. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW,; AMISTAD-II Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). Journal of the American College of Cardiology 2005; 45: 1775-80.
84. Fokkema ML, Vlaar PJ, Vogelzang M, et al. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial. Circulation Cardiovascular Interventions 2009; 2: 323-9.
85. Ludman AJ, Yellon DM, Hasleton J, et al. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial. Heart 2011; 97: 1560-5.
86. Najjar SS, Rao SV, Melloni C, et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. Journal of the American Medical Association 2011; 305: 1863-72.
87. Ferrario M, Arbustini E, Massa M, et al. High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. International Journal of Cardiology 2011; 147: 124-31.
88. Prunier F, Biere L, Gilard M, et al. Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial. American Heart Journal 2012; 163: e1.
89. Gerczuk PZ, Kloner RA,. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. Journal of the American College of Cardiology 2012; 59: 969-78.
90. Sivaraman V, Yellon DM,. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury. Journal of Cardiovascular Pharmacology and Therapeutics 2014; 19: 83-96.
91. Crompton M,. The mitochondrial permeability transition pore and its role in cell death. Biochemical Journal 1999; 341: 233-49.
92. Hausenloy DJ, Lim SY, Ong SG, Davidson SM, Yellon DM,. Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning. Cardiovascular Research 2010; 88: 67-74.
93. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM,. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovascular Research 2002; 55: 534-43.
94. Shanmuganathan S, Hausenloy DJ, Duchen MR, Yellon DM,. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. American Journal of Physiology Heart and Circulatory Physiology 2005; 289: H237-42.
95. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM,. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-6.
96. Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW,. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. European Heart Journal 2006; 27: 2400-5.
97. Desmet W, Bogaert J, Dubois C, et al. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. European Heart Journal 2011; 32: 867-77.
98. Maiese K, Li F, Chong ZZ,. New avenues of exploration for erythropoietin. Journal of the American Medical Association 2005; 293: 90-5.
99. Ott I, Schulz S, Mehilli J, et al. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial. Circulation: Cardiovascular Interventions 2010; 3: 408-13.
100. Voors AA, Belonje AM, Zijlstra F, et al. A single dose of erythropoietin in ST-elevation myocardial infarction. European Heart Journal 2010; 31: 2593-600.
101. Ovize M, Thibault H, Przyklenk K,. Myocardial conditioning: opportunities for clinical translation. Circulation Research 2013; 113: 439-50.
102. Ovize M, Baxter GF, Di Lisa F, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovascular Research 2010; 87: 406-23.
103. Vander Heide RS, Steenbergen C,. Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Circulation Research 2013; 113: 464-77.
104. Mewton N, Rapacchi S, Augeul L, et al. Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model. Basic Research in Cardiology 2011; 106: 1247-57.
105. Mangiacapra F, Wijns W, De Luca G, et al. Thrombus aspiration in primary percutaneous coronary intervention in high-risk patients with ST-elevation myocardial infarction: a real-world registry. Catheterization and Cardiovascular Interventions 2010; 76: 70-6.
106. Heusch G, Kleinbongard P, Bose D, et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation 2009; 120: 1822-36.
107. Heusch G, Kleinbongard P, Skyschally A, Levkau B, Schulz R, Erbel R,. The coronary circulation in cardioprotection: more than just one confounder. Cardiovascular Research 2012; 94: 237-45.
108. Skyschally A, Walter B, Heusch G,. Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning. European Heart Journal 2013; 34: 3314-21.
109. Loubeyre C, Morice MC, Lefevre T, Piechaud JF, Louvard Y, Dumas P,. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. Journal of the American College of Cardiology 2002; 39: 15-21.
110. Meier JJ, Gallwitz B, Schmidt WE, Mugge A, Nauck MA,. Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important? Heart 2004; 90: 9-12.
111. Mensah K, Mocanu MM, Yellon DM,. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? Journal of the American College of Cardiology 2005; 45: 1287-91.
112. Heusch G, Skyschally A, Gres P, van Caster P, Schilawa D, Schulz R,. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. European Heart Journal 2008; 29: 2265-75.
113. Lange M, Redel A, Lotz C, et al. Desflurane-induced postconditioning is mediated by beta-adrenergic signaling: role of beta 1- and beta 2-adrenergic receptors, protein kinase A, and calcium/calmodulin-dependent protein kinase II. Anesthesiology 2009; 110: 516-28.
114. Oikawa M, Yaoita H, Watanabe K, Maruyama Y,. Attenuation of cardioprotective effect by postconditioning in coronary stenosed rat heart and its restoration by carvedilol. Circulation Journal 2008; 72: 2081-6.